Dr. Dean A. Delmastro
Claim this profileMarshfield Medical Center-EC Cancer Center
Studies Cancer
Studies Breast Cancer
9 reported clinical trials
20 drugs studied
Area of expertise
1Cancer
Stage II
HER2 positive
Stage I
2Breast Cancer
HER2 positive
PR positive
ER positive
Affiliated Hospitals
Clinical Trials Dean A. Delmastro is currently running
Atezolizumab + Chemotherapy
for Neuroendocrine Carcinoma
This trial is testing a new treatment combining an immune-boosting drug with standard chemotherapy for patients with a specific type of aggressive cancer that has spread. The goal is to help the immune system fight the cancer and use chemotherapy to kill cancer cells.
Recruiting1 award Phase 2 & 310 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint Ultrahigh (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint Ultrahigh Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
More about Dean A. Delmastro
Clinical Trial Related2 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Dean A. Delmastro has experience with
- Cisplatin
- Atezolizumab
- Internet-based Pain Coping Skills Program
- Cabozantinib S-malate
- Gemcitabine Hydrochloride
- Carboplatin
Breakdown of trials Dean A. Delmastro has run
Cancer
Breast Cancer
Pancreatic Cancer
Pancreatic Neuroendocrine Tumors
Neuroendocrine Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Dean A. Delmastro specialize in?
Dean A. Delmastro focuses on Cancer and Breast Cancer. In particular, much of their work with Cancer has involved Stage II patients, or patients who are HER2 positive.
Is Dean A. Delmastro currently recruiting for clinical trials?
Yes, Dean A. Delmastro is currently recruiting for 6 clinical trials in Eau Claire Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Dean A. Delmastro has studied deeply?
Yes, Dean A. Delmastro has studied treatments such as Cisplatin, Atezolizumab, Internet-based pain coping skills program.
What is the best way to schedule an appointment with Dean A. Delmastro?
Apply for one of the trials that Dean A. Delmastro is conducting.
What is the office address of Dean A. Delmastro?
The office of Dean A. Delmastro is located at: Marshfield Medical Center-EC Cancer Center, Eau Claire, Wisconsin 54701 United States. This is the address for their practice at the Marshfield Medical Center-EC Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.